Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy.

J Soc Cardiovasc Angiogr Interv · 2022 · PMC11308031 · PMID 39130138

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a nonsignificant trendP = .06so close (0.05 < p ≤ 0.1)

There was a nonsignificant trend toward higher cardiovascular (0.7 vs 0.0%; P = .06) and cardiac mortality (0.6 vs 0.0%; P = .08) among the complex lesion cohort ( Supplemental Table S1 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.